Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Gastroenterology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Retracted: Ozanimod▼ in Ulcerative Colitis: Key New Data
February 2025
This article has now been retracted and a retraction statement has been published.
Read more
10
Mins
16 May 2017
Changing the Game in Ulcerative Colitis: The Impact of Gut-Selective Therapy
Effective therapy is warranted early in the course of ulcerative colitis, especially for patients judged at a high risk of colectomy.
7
Mins
16 May 2017
Targeting Disease Progression in Crohn’s Disease: Fighting an Unrelenting Enemy
In the first presentation, Prof Panaccione considered how early treatment of Crohn’s disease (CD) is key for achieving the therapeutic goals, which…
21
Mins
24 Apr 2017
Manejo de la Enfermedad Hemorroidal
Este seminario especializado financiado mediante una contribución independiente realizada por OM/Vifor Pharma reunió a facultativos especializados en…
16
Mins
24 Apr 2017
Haemorrhoidal Disease Management
The scale of HD is difficult to quantify due to patient misconceptions regarding anal health and poor practice both by physicians and the healthcare…
6
Mins
1 Dec 2016
Preventing Collateral Damage in the Inflammatory Bowel Disease Patient: Using Disease Assessment and Prognostic Factors to Optimise Clinical Outcomes
Inflammatory bowel diseases (IBDs) are chronic disabling conditions. Despite the benefits of anti-tumour necrosis factor-α agents in improving quality…
9
Mins
1 Dec 2016
Introducing Biosimilars into Current Inflammatory Bowel Disease Treatment Algorithms
Biosimilars follow a rigorous regulatory approval pathway designed to collect and review the totality of evidence from non-clinical analytical…
7
Mins
1 Dec 2016
Relevance of Patient-Reported Outcomes for the Management of Patients with Inflammatory Bowel Disease
Patient adherence is a major problem in the treatment of inflammatory bowel disease (IBD). Research has shown that improved patient adherence and…
9
Mins
1 Dec 2016
Crohn’s Disease: Supporting Patients in Their Pursuit of Disease Control
The objectives of this symposium were to describe the current unmet needs in the treatment and management of inflammatory bowel diseases (IBDs) in…
Loading posts...
« Previous
1
…
4
5
6
7
8
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View